Claire Roddie, Clinician Scientist at UCL, shared a post on X:
“Check out how CD19CAR-T for Richter’s Transformation stacks up in this UK analysis.
Broadly safe and effective, ORR 70%, 2y PFS 46%.
Risks for poor response- high LDH, non-response bridging, more prior lines.”
Title: CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter’s transformation and response to bridging therapy
Journal: British Journal of Haematology
Authors: Angela Hwang, Amy A. Kirkwood, Maeve O’Reilly, Lorna Neill, Caroline Besley, Shankara Paneesha, Mathew Amrith, Paul Maciocia, Andrea Kuhnl, David Irvine, Jane Norman, Ahmed Abdulgawad, Carlos Gonzalez Arias, Sunil Iyengar, Helen Marr, Satyen Gohil, Claire Roddie
More posts on OncoDaily.